Eurobio Scientific Société anonyme (EPA:ALERS)

France · Delayed Price · Currency is EUR

25.10

0.00 (0.00%)

Oct 2, 2026, 5:35 PM CET

Market Cap	252.71M +1.1%
Revenue (ttm)	172.26M +6.3%
Net Income	7.19M +204.6%
EPS	0.70 +209.4%
Shares Out	10.07M
PE Ratio	35.86
Forward PE	22.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,364
Open	25.10
Previous Close	25.10
Day's Range	25.10 - 25.20
52-Week Range	19.20 - 25.60
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2026

About EPA:ALERS

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies; TQS (Tetanus Quick Stick), a rapid test used in emergency departments or pharmacies to assess the vaccina... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1997

Employees 443

Stock Exchange Euronext Paris

Ticker Symbol ALERS

Full Company Profile

Financial Performance

In 2025, EPA:ALERS's revenue was 168.60 million, an increase of 9.08% compared to the previous year's 154.56 million. Earnings were 4.87 million, an increase of 21.69%.

Financial Statements